Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000573034 | SCV000669748 | likely benign | Hereditary cancer-predisposing syndrome | 2016-01-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001035945 | SCV001199285 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-11-25 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000573034 | SCV002526743 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-10-02 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV005248275 | SCV005898681 | benign | Lynch syndrome 1 | 2024-12-02 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |